PFHpA, a Lesser-Known 'Forever Chemical', Linked to Liver Cancer

Researchers analyzing blood samples across 12 prospective US cohorts found that elevated perfluoroheptanoic acid (PFHpA) levels were associated with higher odds of liver cancer. The nested case-control analysis, published on September 17, 2026, evaluated nine lesser-studied PFAS compounds and identified a statistically significant link exclusively for PFHpA.

Key takeaways

• A September 17, 2026 study in the Journal of the National Cancer Institute found that higher pre-diagnostic blood levels of PFHpA were associated with higher odds of liver cancer (odds ratio 1.78) across 12 prospective US cohorts.
• The observed link was particularly pronounced among men (odds ratio 3.72), for hepatocellular carcinoma (odds ratio 4.53), and for cancers diagnosed within 10 years of blood collection (odds ratio 3.17), while eight other evaluated PFAS showed no association.
• Because PFHpA is an environmental contaminant and packaging byproduct rather than an intentional food additive, it never appears on ingredient lists, meaning food labels cannot identify its presence.
• The findings demonstrate statistical correlation rather than direct causation, emphasizing the need for independent replication and more research on short-chain PFAS.

What happened: who discovered the link?

On September 17, 2026, a research team led by CZ Watling, JL Petrick, BI Graubard, and senior investigators MP Purdue and KA McGlynn published findings in the Journal of the National Cancer Institute.

To conduct the research, the investigators utilized a nested case-control design drawing from 12 long-term, prospective US cohorts. They analyzed baseline serum or plasma collected from 853 individuals who later developed liver cancer, comparing them against 853 matched control participants who remained cancer-free during the follow-up period.

The analysis focused on nine specific PFAS compounds beyond the historically examined chemicals PFOS, PFOA, and PFHxS. Chemical properties for seven-carbon structures like perfluoroheptanoic acid distinguish them from legacy eight-carbon chemicals. Using multivariable-adjusted conditional logistic regression, the researchers contrasted participants in the 90th percentile of blood concentration against those in the 10th percentile to calculate odds ratios.

What changed in PFAS research?

Historically, scientific investigations examining PFAS and liver cancer focused almost entirely on long-chain legacy compounds such as perfluorooctane sulfonate (PFOS), perfluorooctanoic acid (PFOA), and perfluorohexane sulfonate (PFHxS). Prior epidemiological studies on those three legacy compounds yielded conflicting results, failing to demonstrate consistent or clear associations with human liver cancer risk.

This study shifted attention toward shorter-chain and alternative compounds that remain active in industrial and commercial applications. Out of the nine additional PFAS evaluated, perfluoroheptanoic acid (PFHpA) emerged as the sole compound demonstrating a statistically significant association with liver cancer. Comparing blood levels at the 90th percentile with the 10th percentile, the odds of liver cancer were 78% higher (odds ratio 1.78; 95% confidence interval 1.26 to 2.52).

The risk was not uniformly distributed across all subsets. Subgroup evaluations revealed stronger associations among specific patient profiles and diagnostic windows:

• Male participants showed an odds ratio of 3.72 (95% CI 2.10 to 6.59).
• Hepatocellular carcinoma cases showed an odds ratio of 4.53 (95% CI 2.59 to 7.94).
• Individuals diagnosed within 10 years of initial blood collection showed an odds ratio of 3.17 (95% CI 1.80 to 5.57).

The remaining eight PFAS measured in the study showed no statistically significant link to liver cancer.

Who is affected by exposure?

Because PFAS compounds are chemically stable and water-resistant, human exposure to PFHpA occurs broadly across the general population via environmental contamination, drinking water, and everyday consumer products.

Food is one exposure pathway, though tracking specific dietary sources is hard. A separate study of children's diets in the Journal of Exposure Science and Environmental Epidemiology evaluated 110 Hispanic children aged 4 to 11, reporting that higher reported consumption of burritos and cheese correlated with elevated blood concentrations of PFHpA.

Crucially, that pediatric dietary study could not establish where the PFHpA originated. The chemical could have stemmed from agricultural soil, livestock water sources, processing machinery, or food-contact materials such as grease-resistant wrapping paper. Regulators at the U.S. Food and Drug Administration actively test foods for environmental contaminants, noting that PFAS migrate into food chains through both ecological pathways and food packaging.

What it means for shoppers

For everyday consumers reading labels in the grocery aisle, the practical reality is stark: scanning a product packaging label cannot reveal whether it contains PFHpA. PFHpA is never an intentional food ingredient, nutritional component, or approved food additive. As a result, it has no E-number, never appears on ingredient statements, and is omitted entirely from the Nutrition Facts panel.

Shoppers often wonder whether grease-resistant wrappers, microwave bags, or takeout cartons leach these substances into their meals. While regulatory initiatives target packaging materials, such as how the EU Bans PFHxA in Food Packaging Paper From October 10, 2026, retail product labels do not state whether PFHpA or related compounds are present in the packaging substrate.

This makes PFHpA an issue where standard label-reading tools hit an unavoidable barrier. The exposure happens invisibly through contact materials and environmental water supplies rather than listed ingredients.

The background

PFAS compounds earned the moniker 'forever chemicals' due to their carbon-fluorine bonds, which rank among the strongest in organic chemistry. These bonds prevent the compounds from breaking down easily in the natural environment or inside human tissue. Shorter-chain PFAS such as PFHpA (seven carbons) and PFHxA (six carbons) remain in use, which is why the study's authors flag them for further research.

The FDA tests foods for PFAS as environmental contaminants, but testing does not remove background chemicals from soil and water.

It is essential to view these epidemiological findings through a measured scientific lens. The JNCI paper is an observational nested case-control study. It establishes a statistical association, not direct biological causation. Blood concentrations were collected at baseline, but specific dietary histories were not matched directly to individual cancer outcomes in this analysis. Furthermore, because researchers evaluated nine distinct PFAS compounds simultaneously, the isolated correlation with PFHpA could theoretically arise from statistical chance, making replication in separate populations necessary before concluding that food-borne PFAS directly causes liver cancer.

What to watch next

The authors conclude that, given continued use of short-chain PFAS in consumer products, more research on their effects on liver health is warranted.

Key areas to watch over the coming months include:

• Laboratory studies on how, or whether, PFHpA affects the liver.
• Independent replication studies from European and international cohorts to confirm if the male-predominant association with hepatocellular carcinoma holds across diverse geographies.
• FDA updates on total dietary PFAS surveillance and laboratory testing methodologies for agricultural commodities.

Understanding what enters your body starts with complete transparency on food labels. While environmental contaminants require systemic regulatory action, you can inspect packaged food for known additives, emulsifiers, and preservatives using free, evidence-based tools. Scan your next packaged food item with the Aurascan app to read transparent, verified ingredient breakdowns on your phone.